Hancock Jaffe Laboratories, Inc. Gains 42.65%
Fri, Dec 11, 2020 at 05:33 PM
Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ) rocketted at $11.54, representing a gain of 42.6%. On Thu 10 Dec 20, HJLI:NASDAQ hit a New 2-Week High of $8.09. The stock got featured on our News Catalysts scanner on Thu 10 Dec 20 at 08:06 PM in the 'BIOTECH' category. From Fri 27 Nov 20, the stock recorded 44.44% Up Days and 50.00% Green Days
The share price of the company has been moving sideways in recent weeks.
About Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ)
Hancock Jaffe Laboratories Inc development stage medical device company. It develops and sells biological tissue solutions to treat patients with coronary, vascular, end stage renal and peripheral arterial diseases in the United States and Europe.
Top 10 Gainers:
- TPGY (TPGY:NYSE), 116.22%
- MACU (MACU:NASDAQ), 100%
- Solid Biosciences Inc. (SLDB:NASDAQ), 51.62%
- Equus Total Return, Inc. (EQS:NYSE), 46.9%
- Hancock Jaffe Laboratories, Inc. (HJLI:NASDAQ), 42.65%
- vTv Therapeutics Inc. (VTVT:NASDAQ), 41.55%
- Sonoma Pharmaceuticals, Inc. (SNOA:NASDAQ), 41.29%
- NextDecade Corporation (NEXT:NASDAQ), 38%
- Recro Pharma, Inc. (REPH:NASDAQ), 36.81%
- FAT Brands Inc. (FAT:NASDAQ), 28.08%